Szczepański W
Department of Clinical and Experimental Pathomorphology, CMUJ, Kraków.
Pol J Pathol. 1997;48(3):147-57.
The aim of the study was to assess the incidence of both types of liver cell dysplasia and concomitance with cirrhosis, hepatocellular carcinoma (HCC) and positive reaction for HBsAg in the autopsy material and an attempt to determine a relationship between these two types of liver cell dysplasia and hepatocellular carcinoma. Autopsy material included 102 cases of hepatocellular carcinoma, 101 cases of hepatocirrhosis without accompanying cancer and 106 control cases. Histological specimens stained with HE were analyzed for the presence of large liver cell dysplasia (LLCD) according to Anthony et al., small liver cell dysplasia (SLCD) according to Watanabe et al., the presence of macroregenerative nodules (< 8 mm) and antigen HBs (stained with orcein according to Shikata). The detected LLCD were also assessed semiquantitatively taking into account the number of dysplastic areas in a given case. Statistical significance of the results was tested with the chi square test. LLCD was most frequently detected in HCC with concomitant cirrhosis (55.3%), then in cirrhosis without HCC (40.6%), and in HCC without cirrhosis only in 12.5%. LLCD was found significantly more frequently (p < 0.05) in cirrhosis with HCC than in cirrhosis without HCC. Antigen HBs was found in 25.6% of cirrhoses and/or HCC. No significant differences in the presence of HBsAg were seen between the analyzed groups. The incidence of LLCD and HBsAg in controls was significantly lower than in other groups. A mean age at death in case of cirrhosis with HCC subdivided into that with or without LLCD was not significantly different, whereas in case with cirrhosis with LLCD age at death was 10.8 years higher (the difference statistically significant). Analysis of material with respect to gender revealed a high proportion of men in case of HCC with concomitant cirrhosis but without LLCD (13:1). A strong relationship was seen between the presence of positive reaction for HBsAg and LLCD (p < 0.001). Also the intensity of LLCD positively correlated with the presence of HBsAg. Furthermore, a positive correlation was seen between the presence of LLCD and macronodular cirrhosis (posthepatitic). The present findings suggest a closer relation between HBV infection and LLCD than between cirrhosis or HCC and LLCD. Also morphological patterns of LLCD foci do not confirm the hypothesis of some investigators about the precancerous character of these lesions. In the whole current material only seven cases of SLCD were detected. They were all present in cirrhotic livers with concomitant HCC. Both the morphological pattern of these lesions and their sometimes discerned close spatial relation with HCC foci indicate that SLCD is an alternative way of HCC development.
本研究的目的是评估尸检材料中两种类型的肝细胞发育异常的发生率及其与肝硬化、肝细胞癌(HCC)和HBsAg阳性反应的伴发情况,并试图确定这两种类型的肝细胞发育异常与肝细胞癌之间的关系。尸检材料包括102例肝细胞癌、101例无伴发癌症的肝硬化以及106例对照病例。对苏木精-伊红(HE)染色的组织学标本进行分析,以确定是否存在根据安东尼等人标准的大肝细胞发育异常(LLCD)、根据渡边等人标准的小肝细胞发育异常(SLCD)、大再生结节(<8mm)以及HBs抗原(根据志方的方法用orcein染色)。对于检测到的LLCD,还根据给定病例中发育异常区域的数量进行半定量评估。结果的统计学显著性采用卡方检验。LLCD最常出现在伴有肝硬化的HCC中(55.3%),其次是无HCC的肝硬化(40.6%),而在无肝硬化的HCC中仅占12.5%。与无HCC的肝硬化相比,伴有HCC的肝硬化中LLCD的检出率显著更高(p<0.05)。在25.6%的肝硬化和/或HCC中发现了HBs抗原。分析组之间HBsAg的存在情况无显著差异。对照组中LLCD和HBsAg的发生率显著低于其他组。伴有或不伴有LLCD的HCC相关肝硬化患者的平均死亡年龄无显著差异,而伴有LLCD的肝硬化患者的死亡年龄高10.8岁(差异具有统计学显著性)。按性别对材料进行分析发现,伴有肝硬化但无LLCD的HCC病例中男性比例很高(13:1)。HBsAg阳性反应与LLCD之间存在密切关系(p<0.001)。此外,LLCD的强度与HBsAg的存在呈正相关。此外,LLCD的存在与大结节性肝硬化(肝炎后)之间也存在正相关。目前的研究结果表明,HBV感染与LLCD之间的关系比肝硬化或HCC与LLCD之间的关系更密切。此外,LLCD病灶的形态学模式也不支持一些研究者关于这些病变具有癌前特征的假设。在整个现有材料中仅检测到7例SLCD。它们均存在于伴有HCC的肝硬化肝脏中。这些病变的形态学模式及其有时与HCC病灶明显的紧密空间关系均表明SLCD是HCC发展的另一种途径。